文献詳細
文献概要
展望
非定型うつ病―不安障害との併発をめぐって
著者: 貝谷久宣1
所属機関: 1医療法人和楽会パニック障害研究センター
ページ範囲:P.840 - P.852
文献購入ページに移動はじめに
パニック障害(PD)の臨床に従事していると,それに伴ううつ病を避けて通ることはできず,その治療には難渋する。PDに伴ううつ病に関する研究を探すと,その頻度については多くの文献が見つかったが30),臨床症状を詳しく記載した論文はそれほど多くなかった。数少ない中でVan Valkenburgら65)は,PDに伴ううつ病は焦燥感が強く,心気症や離人症が多く慢性化の傾向が強い,さらに,治療反応が悪く社会的予後が悪いことを記していたが,治療に関する記載はなかった。その後,ロンドンの聖トーマス病院のWestとDally67)による不安・恐怖症が前駆するうつ病の論文とめぐり会えた。この報告の貴重さは“まず治療ありき”である。この研究は,モノアミン酸化酵素阻害薬(MAOI)が奏効したうつ病群を取り出し,それが従来のうつ病と異なる臨床特徴を持つことを示し,現代の非定型うつ病(AD)概念の端緒を開いた。この論文は,半世紀経た今日,いまだ臨床的価値を失っていない。
本稿ではAD概念成立の経緯をたどり,現代精神医学におけるADの臨床的意義を述べ,最後に筆者のAD成立機序の仮説を提出する。
パニック障害(PD)の臨床に従事していると,それに伴ううつ病を避けて通ることはできず,その治療には難渋する。PDに伴ううつ病に関する研究を探すと,その頻度については多くの文献が見つかったが30),臨床症状を詳しく記載した論文はそれほど多くなかった。数少ない中でVan Valkenburgら65)は,PDに伴ううつ病は焦燥感が強く,心気症や離人症が多く慢性化の傾向が強い,さらに,治療反応が悪く社会的予後が悪いことを記していたが,治療に関する記載はなかった。その後,ロンドンの聖トーマス病院のWestとDally67)による不安・恐怖症が前駆するうつ病の論文とめぐり会えた。この報告の貴重さは“まず治療ありき”である。この研究は,モノアミン酸化酵素阻害薬(MAOI)が奏効したうつ病群を取り出し,それが従来のうつ病と異なる臨床特徴を持つことを示し,現代の非定型うつ病(AD)概念の端緒を開いた。この論文は,半世紀経た今日,いまだ臨床的価値を失っていない。
本稿ではAD概念成立の経緯をたどり,現代精神医学におけるADの臨床的意義を述べ,最後に筆者のAD成立機序の仮説を提出する。
参考文献
1) Alpert JE, Uebelacker LA, McLean NE, et al:Social phobia, avoidant personality disorder and atypical depression:Co-occurrence and clinical implications. Psychol Med 27:627-633, 1997
2) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders. Third Edition. American Psychiatric Association, Washington, DC, 1980
3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Text Revision. American Psychiatric Association, Washington, DC, 2000
4) Angst J:The epidemiology of depressive disorders. Eur Neuropsychopharmacol 5(Suppl):95-98, 1995
5) Angst J, Gamma A, Benazzi F, et al:Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci 256:44-54, 2006
6) Angst J, Gamma A, Sellaro R, et al:Toward validation of atypical depression in the community:Results of the Zurich cohort study. J Affect Disord 72:125-138, 2002
7) Asnis GM, McGinn LK, Sanderson WC:Atypical depression:Clinical aspects and noradrenergic function. Am J Psychiatry 152:31-36, 1995
8) Beesdo K, Bittner A, Pine DS, et al:Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 64:903-912, 2007
9) Benazzi F:Prevalence and clinical features of atypical depression in depressed outpatients:A 467-case study. Psychiatry Res 86:259-265, 1999
10) Benazzi F:Early-onset versus late-onset atypical depression:Unipolar and bipolar II. J Affect Disord 61:95-99, 2000
11) Bittner A, Goodwin RD, Wittchen HU, et al:What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 65:618-626, 2004
12) Clark LA, Watson D:Tripartite model of anxiety and depression:Psychometric evidence and taxonomic implications. J Abnorm Psychol 100:316-336, 1991
13) Derecho CN, Wetzler S, McGinn LK, et al:Atypical depression among psychiatric inpatients:Clinical features and personality traits. J Affect Disord 39:55-59, 1996
14) Fava M, Uebelacker LA, Alpert JE, et al:Major depressive subtypes and treatment response. Biol Psychiatry 42:568-576, 1997
15) Fountoulakis KN, Iacovides A, Nimatoudis I, et al:Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry 14:426-433, 1999
16) Gabbard GO:Two subtypes of narcissistic personality disorder. Bull Menninger Clin 53:527-532, 1989
17) Goodwin R, Olfson M:Treatment of panic attack and risk of major depressive disorder in the community. Am J Psychiatry 158:1146-1148, 2001
18) Grant BF, Hasin DS, Blanco C, et al:The epidemiology of social anxiety disorder in the United States:Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66:1351-1361, 2005
19) Hasin DS, Goodwin RD, Stinson FS, et al:Epidemiology of major depressive disorder:Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 62:1097-1106, 2005
20) Hordern A:The antidepressant drugs. Int J Psychiatry 2:48-77, 1966 Review
21) Horwath E, Johnson J, Weissman MM, et al:The validity of major depression with atypical features based on a community study. J Affect Disord 26:117-125, 1992
22) Husain MM, McClintock SM, Rush AJ, et al:The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 69:406-411, 2008
23) 貝谷久宣:シンポジウム 不安とうつの心身医学 パニック性不安うつ病.心身医学 44:361-367,2004
24) 貝谷久宣:不安―恐怖症の心模様.講談社,2008
25) 貝谷久宣:不安・抑うつ発作―見過ごされていた重要な症状.不安障害研究 1:42-48,2009
26) 貝谷久宣:不安うつ病.内科 105:275-279,2010
27) 貝谷久宣:非定型うつ病.中込和幸 編,専門医のための精神科臨床リュミエール.15 難治性精神障害へのストラテジー.中山書店,pp63-75,2010
28) 貝谷久宣,林恵美:PDと非定型うつ病との関係―パニック性不安うつ病(3).樋口輝彦,久保木富房,貝谷久宣,不安・抑うつ臨床研究会 編,うつ病の亜型分類.日本評論社,pp41-68,2003
29) 貝谷久宣,井上顕,山中学:PDと双極性障害.こころの科学 131:57-61,2007
30) 貝谷久宣,宮前義和:パニック障害における抑うつ状態 パニック性不安うつ病(1)頻度と症状.貝谷久宣,不安・抑うつ臨床研究会 編,パニック障害研究最前線.日本評論社,pp55-78,2000
31) Kendler KS, Eaves LJ, Walters EE, et al:The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53:391-399, 1996
32) Kessler RC, Chiu WT, Jin R, et al:The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63:415-424, 2006
33) Kessler RC, Stang PE, Wittchen HU, et al:Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 55:801-808, 1998
34) Klein DF, Gittelman R, Quitkin F, et al:Dysphorias. Diagnosis and Drug Treatment of Psychiatric Disorders:Adults and Children. Second Edition. The Williams & Wildins, Baltimore, pp243-250 and 438-441, 1980
35) Levitan RD, Lesage A, Parikh SV, et al:Reversed neurovegetative symptoms of depression:A community study of Ontario. Am J Psychiatry 154:934-940, 1997
36) Liebowitz MR:Depression with anxiety and atypical depression. J Clin Psychiatry 54(Supple):10-14, 1993
37) Liebowitz MR, Klein DF:Hysteroid dysphoria. Psychiatric Clinics of North America 2:555-575, 1979
38) Liebowitz MR, Quitkin FM, Stewart JW, et al. Phenelzine v imipramine in atypical depression. A preliminary report. Arch Gen Psychiatry 41:669-677, 1984
39) Mannuzza S, Schneier FR, Chapman TF, et al:Generalized social phobia. Reliability and validity. Arch Gen Psychiatry 52:230-237, 1995
40) Matza LS, Revicki DA, Davidson JR, et al:Depression with atypical features in the National Comorbidity Survey:Classification, description, and consequences. Arch Gen Psychiatry 60:817-826, 2003
41) McGrath PJ, Stewart JW, Harrison W, et al:A placebo-controlled trial of L-deprenyl in atypical depression. Psychopharmacol Bull 25:63-67, 1989
42) Mosing MA, Gordon SD, Medland SE, et al:Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia:A twin study. Depress Anxiety. 26:1004-1011, 2009
43) Nierenberg AA, Pava JA, Clancy K, et al:Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry 40:691-696, 1996
44) 野口恭子,正木美奈,小松智賀,他:非定型うつ病に見られるPTSD症状.不安障害研究 2:188,2010
45) 大前晋:非定型うつ病という概念―4種の定義.精神経誌 112:3-22,2010
46) Parker G, Roy K, Mitchell P, et al:Atypical depression:A reappraisal. Am J Psychiatry 159:1470-1479, 2002 Review
47) Perugi G, Akiskal HS, Lattanzi L, et al:The high prevalence of "soft" bipolar(II)features in atypical depression. Compr Psychiatry 39:63-71, 1998
48) Posternak MA, Zimmerman M:The prevalence of atypical features across mood, anxiety, and personality disorders. Compr Psychiatry 43:253-262, 2002
49) Quitkin FM, McGrath PJ, Stewart JW, et al:Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Arch Gen Psychiatry 47:935-941, 1990
50) Robertson HA, Lam RW, Stewart JN, et al:Atypical depressive symptoms and clusters in unipolar and bipolar depression. Acta Psychiatr Scand 94:421-427, 1996
51) Roth M:The phobic anxiety-depersonalization syndrome [Abridged]. Proc R Soc Med 52:587-595, 1959
52) Roy-Byrne PP, Stang P, Wittchen HU, et al:Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 176:229-235, 2000
53) Sargant W:Some newer drugs in the treatment of depression and their relation to other somatic treatments. Psychosomatics 1:14-17, 1960
54) Schneier FR, Blanco C, Campeas R, et al:Citalopram treatment of social anxiety disorder with comorbid major depression. Depress Anxiety 17:191-196, 2003
55) Sheehan DV, Sheehan KH:The classification of anxiety and hysterical states. Part I. Historical review and empirical delineation. J Clin Psychopharmacol 2:235-244, 1982
56) Souery D, Oswald P, Massat I, et al:Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder:results from a European multicenter study. J Clin Psychiatry 68:1062-1070, 2007
57) Spitzer RL, Williams JBW:Hysteroid Dysphoria:An Unsuccessful Attempt to Demonstrate Its Syndromal Validity. Am J Psychiatry 139:1286-1291, 1982
58) Stein MB, Tancer ME, Uhde TW:Major depression in patients with panic disorder:Factors associated with course and recurrence. J Affect Disord 19:287-296, 1990
59) Stewart JW, McGrath PJ, Quitkin FM, et al:DSM-IV depression with atypical features:Is it valid? Neuropsychopharmacology 34:2625-2632, 2009
60) Stewart JW, McGrath PJ, Rabkin JG, et al:Atypical depression. A valid clinical entity? Psychiatr Clin North Am 16:479-495, 1993
61) Stunkard AJ, Fernstrom MH, Price A, et al:Direction of weight change in recurrent depression. Consistency across episodes. Arch Gen Psychiatry 47:857-860, 1990
62) Sullivan PF, Kessler RC, Kendler KS:Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. Am J Psychiatry 155:1398-1406, 1998
63) Thase ME:Atypical depression:useful concept, but it's time to revise the DSM-IV criteria. Neuropsychopharmacology 34:2633-2641, 2009
64) Thase ME, Carpenter L, Kupfer DJ, et al:Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull:27:17-22, 1991
65) Van Valkenburg C, Winokur G, Behar D, et al:Depressed women with panic attacks. J Clin Psychiatry 45:367-369, 1984
66) Weissman MM, Leckman JF, Merikangas KR, et al:Depression and anxiety disorders in parents and children. Results from the Yale family study. Arch Gen Psychiatry 41:845-852, 1984
67) West ED, Dally PJ:Effects of iproniazid in depressive syndromes. Br Med J 1:1491-1494, 1959
68) Zisook S, Schuter SR, Gallagher T, et al:Atypical depression in an outpatient psychiatry population. Depression 1:268-274, 1993
掲載誌情報